Humacyte, Inc. (HUMA)
(Delayed Data from NSDQ)
$5.20 USD
-0.25 (-4.59%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $5.30 +0.10 (1.92%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/14/2024
Time: -- |
9/2024 | $-0.25 | 0.00% |
Earnings Summary
For their last quarter, Humacyte, Inc. (HUMA) reported earnings of -$0.27 per share, missing the Zacks Consensus Estimate of -$0.23 per share. This reflects a negative earnings surprise of 17.39%. Look out for HUMA's next earnings release expected on November 14, 2024. For the next earning release, we expect the company to report earnings of -$0.25 per share, reflecting no change in earnings compared to the year-ago quarter.
Earnings History
Price & Consensus
Zacks News for HUMA
Humacyte's (HUMA) ATEV BLA Review Period Extended by FDA
HUMA: What are Zacks experts saying now?
Zacks Private Portfolio Services